• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by LHC Group (Amendment)

    1/26/23 8:52:15 AM ET
    $LHCG
    Medical/Nursing Services
    Health Care
    Get the next $LHCG alert in real time by email
    SC 13G/A 1 us50187a1079_012623.txt us50187a1079_012623.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) LHC GROUP INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 50187A107 -------------------------------------------------------- (CUSIP Number) December 31, 2022 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 50187A107 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 4563775 (6) Shared voting power 0 (7) Sole dispositive power 4625583 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 4616338 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 14.9% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- LHC GROUP INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 901 HUGH WALLIS ROAD SOUTH LAFAYETTE LA 70508 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 55 East 52nd Street New York, NY 10055 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 4616338 Percent of class 14.9% Number of shares as to which such person has: Sole power to vote or to direct the vote 4563775 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 4625583 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of LHC GROUP INC. No one person's interest in the common stock of LHC GROUP INC is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 26, 2023 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Life Limited BlackRock Advisors, LLC Aperio Group, LLC BlackRock (Netherlands) B.V. BlackRock Fund Advisors* BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Japan Co., Ltd. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock (Luxembourg) S.A. BlackRock Investment Management (Australia) Limited BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BLACKROCK, INC., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Christopher Meade, Daniel Waltcher, Una Neary, Richard Cundiff, Charles Park, Enda McMahon, Arlene Klein, Con Tzatzakis, Karen Clark, David Maryles, Daniel Ronnen, John Stelley, Daniel Riemer, Elizabeth Kogut, Maureen Gleeson, Daniel Kalish and Spencer Fleming acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, is acting certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, Including without limitation Forms 3, 4, 5, 13D, 13F, 13G and 13H and any amendments to any of the Foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 8th day of December, 2015 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 2nd day of January, 2019. BLACKROCK, INC. By:_ /s/ Daniel Waltcher Name: Daniel Waltcher Title: Deputy General Counsel
    Get the next $LHCG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LHCG

    DatePrice TargetRatingAnalyst
    4/4/2022$172.00 → $170.00Outperform → Sector Perform
    RBC Capital Mkts
    3/10/2022$175.00 → $185.00Buy
    Truist Securities
    2/28/2022$184.00 → $181.00Outperform
    Credit Suisse
    2/24/2022$190.00 → $170.00Buy
    Benchmark
    11/10/2021$149.00 → $151.00Market Perform
    SVB Leerink
    11/5/2021$207.00 → $171.00Equal-Weight
    Barclays
    11/5/2021$192.00 → $180.00Outperform
    RBC Capital
    11/5/2021$191.00 → $184.00Outperform
    Credit Suisse
    More analyst ratings

    $LHCG
    SEC Filings

    See more
    • SEC Form S-8 POS filed by LHC Group

      S-8 POS - LHC Group, Inc (0001303313) (Filer)

      2/22/23 4:03:26 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits

      8-K - LHC Group, Inc (0001303313) (Filer)

      2/22/23 8:30:56 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form 10-K filed by LHC Group

      10-K - LHC Group, Inc (0001303313) (Filer)

      2/22/23 6:03:38 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Reed W Earl Iii returned $23,595,490 worth of shares to the company (138,797 units at $170.00), closing all direct ownership in the company

      4 - LHC Group, Inc (0001303313) (Issuer)

      2/22/23 4:39:24 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form 4: Nixon Ronald T returned $4,607,000 worth of shares to the company (27,100 units at $170.00), closing all direct ownership in the company

      4 - LHC Group, Inc (0001303313) (Issuer)

      2/22/23 4:38:04 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form 4: Azare Monica F returned $5,185,000 worth of shares to the company (30,500 units at $170.00), closing all direct ownership in the company

      4 - LHC Group, Inc (0001303313) (Issuer)

      2/22/23 4:38:30 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • LHC Group downgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts downgraded LHC Group from Outperform to Sector Perform and set a new price target of $170.00 from $172.00 previously

      4/4/22 7:19:32 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • Truist Securities reiterated coverage on LHC Group with a new price target

      Truist Securities reiterated coverage of LHC Group with a rating of Buy and set a new price target of $185.00 from $175.00 previously

      3/10/22 10:10:03 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • Credit Suisse reiterated coverage on LHC Group with a new price target

      Credit Suisse reiterated coverage of LHC Group with a rating of Outperform and set a new price target of $181.00 from $184.00 previously

      2/28/22 10:39:19 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Leadership Updates

    Live Leadership Updates

    See more
    • Agape Care Group Appoints Carry vandenMaagdenberg as Its Chief Technology and Innovation Officer and Matt Winer to Chief Operations Officer Post

      Agape Care Group, a leading hospice and palliative care provider, announced today that it is has appointed Carry vandenMaagdenberg as its Chief Technology and Innovation Officer and welcomes Matt Winer to the company as its Chief Operations Officer. Both leaders are health care industry veterans who will lead Agape Care Group forward as it continues to serve a growing number of patients across the Southeast region. Winer joins Agape Care Group from LHC Group (NASDAQ:LHCG) where he led the company's Home Health Division in the Northeast. He has health care experience in South Carolina, having served in operational leadership roles for MUSC Health based in Charleston. He has also led teams i

      4/16/21 2:47:00 PM ET
      $LHCG
      $AMED
      Medical/Nursing Services
      Health Care
    • LHC Group announces corporate governance changes for its 2021 annual meeting

      LAFAYETTE, La., Feb. 17, 2021 /PRNewswire/ -- LHC Group, Inc. (NASDAQ: LHCG) announced a number of corporate governance and board changes that will go into effect with the company's annual shareholder meeting on June 10, 2021. These changes include a mandatory retirement age of 75 for board members as well as the appointment of new chairs of the audit, compensation, corporate development and nominating and corporate governance committees. In addition, LHC Group announced that W.J. "Billy" Tauzin, will retire from the board, effective June 10, 2021.  Following a long and distinguished career representing Louisiana's Third Congressional District in the U.S. House of Representatives, Congressm

      2/17/21 4:01:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UFP Industries Set to Join S&P MidCap 400; Otter Tail to Join S&P SmallCap 600

      NEW YORK, Feb. 16, 2023 /PRNewswire/ -- S&P SmallCap 600 constituent UFP Industries Inc. (NASD: UFPI) will replace LHC Group Inc. (NASD: LHCG) in the S&P MidCap 400, and Otter Tail Corp. (NASD: OTTR) will replace UFP Industries in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 23. S&P 500 constituent UnitedHealth Group Inc. (NYSE:UNH) is acquiring LHC Group in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effectiv

      2/16/23 6:04:00 PM ET
      $LHCG
      $OTTR
      $SPGI
      $UFPI
      Medical/Nursing Services
      Health Care
      Electric Utilities: Central
      Utilities
    • LHC Group announces third quarter 2022 financial results

      LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea

      11/2/22 4:15:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group to report third quarter 2022 earnings results on November 2, 2022

      LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t

      10/19/22 7:00:00 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Financials

    Live finance-specific insights

    See more
    • LHC Group announces third quarter 2022 financial results

      LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea

      11/2/22 4:15:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group to report third quarter 2022 earnings results on November 2, 2022

      LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t

      10/19/22 7:00:00 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • LHC Group announces second quarter 2022 financial results

      LAFAYETTE, La., Aug. 3, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results Net service revenue increased 5.5% to $576.2 million.Net income attributable to LHC Group's common stockholders was $10.6 million, or $0.35 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $29.8 million, or $0.98 adjusted earnings per diluted share.Adjusted EBITDA was $53.0 million.A reconciliation of all non-GAAP financial results in this release appears o

      8/3/22 4:15:00 PM ET
      $LHCG
      Medical/Nursing Services
      Health Care

    $LHCG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by LHC Group (Amendment)

      SC 13G/A - LHC Group, Inc (0001303313) (Subject)

      1/26/23 8:52:15 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by LHC Group (Amendment)

      SC 13G/A - LHC Group, Inc (0001303313) (Subject)

      7/11/22 9:48:31 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by LHC Group (Amendment)

      SC 13G/A - LHC Group, Inc (0001303313) (Subject)

      2/10/22 8:22:29 AM ET
      $LHCG
      Medical/Nursing Services
      Health Care